| 000 | 01527 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250518014030.0 | ||
| 264 | 0 | _c20200330 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1873-2607 | ||
| 024 | 7 |
_a10.1016/j.amepre.2018.09.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeeds, Ira L | |
| 245 | 0 | 0 |
_aCost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults. _h[electronic resource] |
| 260 |
_bAmerican journal of preventive medicine _c02 2019 |
||
| 300 |
_a196-204 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aCost-Benefit Analysis _xstatistics & numerical data |
| 650 | 0 | 4 | _aDecision Trees |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMass Vaccination _xeconomics |
| 650 | 0 | 4 |
_aMeningococcal Infections _xeconomics |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup B _ximmunology |
| 650 | 0 | 4 | _aQuality-Adjusted Life Years |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aNamasivayam, Vasanthkumar | |
| 700 | 1 | _aBamogo, Assanatou | |
| 700 | 1 | _aSankhla, Prithvi | |
| 700 | 1 | _aThayer, Winter M | |
| 773 | 0 |
_tAmerican journal of preventive medicine _gvol. 56 _gno. 2 _gp. 196-204 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amepre.2018.09.020 _zAvailable from publisher's website |
| 999 |
_c29185830 _d29185830 |
||